ID: ALA3680847

Max Phase: Preclinical

Molecular Formula: C31H36F3N3O2S

Molecular Weight: 571.71

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)(C)[C@H](c1nc(-c2cc(F)ccc2F)sc1Cc1ccccc1)N(C[C@@H]1CNC[C@@H]1F)C(=O)[C@@H]1CCCO1

Standard InChI:  InChI=1S/C31H36F3N3O2S/c1-31(2,3)28(37(18-20-16-35-17-24(20)34)30(38)25-10-7-13-39-25)27-26(14-19-8-5-4-6-9-19)40-29(36-27)22-15-21(32)11-12-23(22)33/h4-6,8-9,11-12,15,20,24-25,28,35H,7,10,13-14,16-18H2,1-3H3/t20-,24-,25-,28-/m0/s1

Standard InChI Key:  DLZSFWQZJYELDJ-QIBSBUDHSA-N

Associated Targets(Human)

Kinesin-like protein 1 1720 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 571.71Molecular Weight (Monoisotopic): 571.2480AlogP: 6.33#Rotatable Bonds: 8
Polar Surface Area: 54.46Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 9.47CX LogP: 6.47CX LogD: 4.42
Aromatic Rings: 3Heavy Atoms: 40QED Weighted: 0.34Np Likeness Score: -0.85

References

1.  (2014)  Oxazole and thiazole compounds as KSP inhibitors, 

Source

Source(1):